By Gareth MacDonald+Gareth MACDONALD, 23-Jan-2015BASF will spend €56m ($62m) to increase production capacity for the excipient PVP by expanding existing plants and introducing manufacturing capabilities at its facility in Shanghai, China.

http://www.in-pharmatechnologist.com/Ingredients/BASF-to-take-on-Asian-PVP-producers-and-target-generics-firms-with-new-capacity-in-China